Needle bleb revision with bevacizumab and mitomycin C compared with mitomycin C alone for failing filtration blebs.

PURPOSE To report the 6-month comparative outcomes and bleb morphology for needle revision with bevacizumab and mitomycin C (MMC) versus MMC alone of failed trabeculectomy and ExPRESS shunt blebs. METHODS Patients undergoing bleb needle revision procedures were enrolled in this study. All patients received a subconjunctival injection of 0.1 mL MMC (0.4 mg… CONTINUE READING